Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
V.AFM: Record Fy2024 & Q4 ‘24 Tin Production Fy2025 Production Guidance Exploration Success (click to learn more)
Noble Acquires Property with Significant Uranium, Rare Earth, Phosphorus & Silver Mineralization (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
IMV Inc
IMVIF
Healthcare
Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:IMVIF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 16, 2023 4:17pm
Nothing for shareholders
"The Monitor continues to review the additional information and supporting evidence when provided, and claims summaries will continue to be revised based on steps taken to
...more
(43)
•••
Breakthorough1
X
Comment by
Breakthorough1
on Aug 16, 2023 4:04pm
RE:Third report - Horizon
There are no succesful bids. Because no bid can pay the debt and everything goes to Horizon? "As mentioned in the Second Report, by 5:00 pm (Halifax Time) on July 10, 2023 (the “Bid
...more
Freegold Extends Mineralization Intersecting 1.88 g/t Au over 54.2m and 1.58 g/t Au over 60m
posted Jan 18, 2025 9:00am by
Freegold Ventures Limited
-
|
Results from Golden Summit in Alaska includes higher grade at depth and to the west. Hole GS2411:157 g/t Au over 3 metres from 299 metres, 1.88 g/t Au over 54.2 metres starting at 499.8 metres, and 1.58 g/t Au over 60 metres from 743 metres. Hole GS2147 showed higher grade within the SSW trend with 1.25 g/t Au over 56.5 metres from 24 metres and 196.5 g/t Au over 1.7 metres from 298.5 metres ...read more
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 16, 2023 3:50pm
Third report - Horizon
"Subsequent to the Bid Deadline, Horizon Technology Finance Corporation (“Horizon”), notified the Monitor and the IMV Group of its intention to use its secured debt as
...more
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 16, 2023 8:08am
At the court by friday the 18th
The outcome is very soon: "The Monitor understands that the IMV Group intends to be back before this Honourable Court by August 18, 2023 for a further update and to seek approval of a
...more
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 15, 2023 3:15pm
August 11 2022
“Starting with an early look at our VITALIZE data in the third quarter of 2022 and continuing through mid-2023, we expect to communicate results and translational data from all our active clinical
...more
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 15, 2023 7:29am
March 17th 2021. Another when/will
" Hepatocellular Carcinoma (liver) HCC indication, IMV and its partner Merck have decided to adjust some of the enrollment criteria in order to accelerate enrollment rates. An update will be
...more
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 14, 2023 3:18pm
16th March - suggesting he knew the "mechanics"?
"Now the exact mechanics and details of what that collaboration is going to be, Joe, I can’t talk to, but these aren’t conversations that we started yesterday. This is an evolution of that. And
...more
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 14, 2023 10:26am
17 March 2021
"Based on these results, IMV recently engaged with the FDA which provided productive feedback. The Company is working with Merck to finalize the protocol of the Phase 2b clinical study which is
...more
(3)
•••
antigua1987
X
Post by
antigua1987
on Aug 14, 2023 9:21am
Another ir SOS lands role
disgusting career. what useless types do.
(43)
•••
Breakthorough1
X
Comment by
Breakthorough1
on Aug 14, 2023 4:13am
RE:From 86% (then 76%) to 46.2% ORR in PDL1+
The OS is very good though: 10,1 months ITT; 17,4 months PDL1+. And with justification of MOA: 24,2 months in those patients with ELISpPlot response tu survivin; 24, 2 months in those with injection
...more
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 14, 2023 12:14am
From 86% (then 76%) to 46.2% ORR in PDL1+
That's a good drop since the ASH 2020 disclosed data till the 2023 publication of SPiReL results... https://onlinelibrary.wiley.com/doi/10.1111/ejh.13982
(43)
•••
Breakthorough1
X
Comment by
Breakthorough1
on Aug 13, 2023 7:37am
RE:May 12 2021
Well, not exactly. But the study was "finished" in December 2021 and only bladder data were released (april 2022).
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 13, 2023 7:35am
May 12 2021
Again, "will" depending on "when": Maveropepimut-S: Phase 2 Basket Trial in Multiple Advanced Metastatic Solid Tumors Enrollment continues for subjects with metastatic bladder
...more
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 13, 2023 2:54am
Covid timeline (from "concerned shareholder")
" On March 30, 2020, IMV announced that its goal was
...more
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 13, 2023 2:47am
July 14th 2020
"Next milestones are anticipated as we commence phase 1 clinical trials this summer with results in the Fall of 2020. Once results are published, we plan to initiate phase 2 clinical trials in
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Exploring sensor-based ore sorting, a technology using X-ray analysis and electromagnetic induction
Have you held units of a TD mutual fund, other than through a discount broker? Learn more.
Tribe Announces Preliminary Q4-2024 Results, Achieving Positive Adjusted EBITDA and Increased Revenue Run-Rate